Ricky Goldwasser
Stock Analyst at Morgan Stanley
Total Price Targets
8
Stocks Covered
7
Sectors
Healthcare
Most Recent
Jun 22, 2022
Stocks Covered by Ricky Goldwasser
| Symbol | Company | Latest Target | Current Price | Upside | # Targets | Last Updated |
|---|---|---|---|---|---|---|
| CI | Cigna Corporation | $296.00 | $283.69 | +4.3% | 1 | Jun 22, 2022 |
| CAH | Cardinal Health, Inc. | $74.00 | $195.04 | -62.1% | 1 | Apr 16, 2022 |
| MCK | McKesson Corporation | $370.00 | $817.15 | -54.7% | 2 | Apr 16, 2022 |
| COR | Cencora, Inc. | $142.00 | $305.35 | -53.5% | 1 | Dec 17, 2021 |
| CNC | Centene Corporation | $109.00 | $53.41 | +104.1% | 1 | Dec 17, 2021 |
| CVS | CVS Health Corporation | $125.00 | $82.34 | +51.8% | 1 | Dec 13, 2021 |
| UNH | UnitedHealth Group Incorporated | $526.00 | $370.14 | +42.1% | 1 | Dec 1, 2021 |
Recent Activity
- Jun 22, 2022— Set$296.00price target onCI(Cigna Corporation)
- Apr 16, 2022— Set$370.00price target onMCK(McKesson Corporation)
- Apr 16, 2022— Set$74.00price target onCAH(Cardinal Health, Inc.)
- Dec 17, 2021— Set$109.00price target onCNC(Centene Corporation)
- Dec 17, 2021— Set$142.00price target onCOR(Cencora, Inc.)
- Dec 17, 2021— Set$292.00price target onMCK(McKesson Corporation)
- Dec 13, 2021— Set$125.00price target onCVS(CVS Health Corporation)
- Dec 1, 2021— Set$526.00price target onUNH(UnitedHealth Group Incorporated)
Frequently Asked Questions
Who is Ricky Goldwasser?
Ricky Goldwasser is a stock analyst at Morgan Stanley covering 7 stocks primarily in Healthcare. They have issued 8 price targets since Dec 1, 2021.
What stocks does Ricky Goldwasser cover?
Ricky Goldwasser currently covers 7 stocks, including MCK, CI, CAH, COR, CNC.
What is Ricky Goldwasser's latest price target?
Ricky Goldwasser's most recent price target was $296.00 on CI (Cigna Corporation), set on Jun 22, 2022.
What is Ricky Goldwasser's highest price target?
Ricky Goldwasser's highest issued price target is $526.00 on UNH, set on Dec 1, 2021.
More Analysts at Morgan Stanley
Coverage based on publicly published price targets. Not investment advice.